The Trump administration is implementing a series of new rules and administrative changes at federal funding agencies that critics say are designed to make scientific research so burdensome that many researchers may simply give up. The measures, which include grant freezes, new layers of political review, and restrictions on international collaboration, have raised concerns that the administration is systematically dismantling the U.S. scientific research enterprise.
Daniel Malinsky, an assistant professor of biostatistics at Columbia University’s Mailman School of Public Health, described the situation as «death by a thousand cuts» in a recent analysis. He compared the strategy to the gradual disinvestment seen in public school systems or public transportation networks, where resources are strategically withdrawn until the institution becomes barely functional, leading users to seek alternatives elsewhere.
At the heart of the controversy are new requirements imposed by the administration on agencies such as the National Institutes of Health (NIH). Researchers report that political appointees are now conducting additional reviews of grant proposals, searching for forbidden keywords such as «disparity» and «marginalized.» These reviews, which add weeks or months to the approval process, are seen as an attempt to steer research away from topics that the administration finds politically inconvenient.
The NIH, which is the largest public funder of biomedical research in the world, has also experienced grant freezes and administrative disarray, according to multiple reports. Scientists say that the uncertainty surrounding funding has already led some labs to scale back their work, while others are considering leaving academia or moving their research overseas.
«It appears that the endgame of the Trump administration’s attacks on science and the research funding ecosystem is similar to what we’ve seen in other public institutions,» Malinsky wrote. He pointed to a pattern of strategic disinvestment that ultimately makes it «reasonable to scrap the thing entirely, or re-direct public funds to private companies as contractors.»
The new rules also target international collaboration, which has long been a cornerstone of American scientific leadership. Proposed restrictions would make it more difficult for U.S.-based researchers to work with foreign colleagues, particularly those from countries that the administration views as competitors. Scientists warn that this could isolate the United States from the global research community and slow the pace of discovery in critical fields such as medicine, climate science, and artificial intelligence.
The administration’s actions have drawn sharp criticism from scientific organizations, university leaders, and members of Congress. The American Association for the Advancement of Science (AAAS) issued a statement warning that the policies «threaten to undermine decades of progress in biomedical research, public health, and innovation.» The association noted that federal funding has been responsible for many of the most significant scientific advances of the past century, including the development of vaccines, cancer treatments, and renewable energy technologies.
Supporters of the administration’s approach argue that the new rules are necessary to ensure that taxpayer dollars are spent on research that aligns with national priorities and to eliminate what they describe as «wasteful» or «politically motivated» science. However, critics counter that the review process is itself politically motivated and that the administration is targeting research on topics such as health disparities, environmental justice, and social inequality.
The impact of the changes is already being felt in laboratories across the country. Researchers report that grant applications that were once routinely approved are now being delayed or rejected for reasons that appear unrelated to scientific merit. Some scientists say they are spending more time on administrative paperwork and less time on actual research, while others are reconsidering their career paths.
«The goal seems to be to make scientists’ work so difficult that they simply give up,» Malinsky said. He noted that the cumulative effect of the new rules could be a «brain drain» as talented researchers leave the United States for countries with more supportive research environments.
The situation has also raised concerns about the long-term competitiveness of the United States in science and technology. Historically, the U.S. has been a global leader in research and development, attracting top talent from around the world. But the current policies, critics say, risk ceding that leadership to other nations, particularly China, which has been investing heavily in its own research infrastructure.
As the debate continues, scientists are calling on the administration to reverse course and restore the independence of federal funding agencies. They argue that scientific progress depends on the ability of researchers to pursue knowledge without political interference and that the current policies are a threat not only to individual careers but to the nation’s scientific enterprise as a whole.
